Get the Stockscreener App
3.74
1.77%
0.06
Maravai Lifesciences Holdings Inc stock is traded at $3.74, with a volume of 749.23K.
It is up +1.77% in the last 24 hours and up +9.82% over the past month.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
See More
Previous Close:
$3.68
Open:
$3.7
24h Volume:
749.23K
Relative Volume:
0.51
Market Cap:
$543.11M
Revenue:
$288.95M
Net Income/Loss:
$-119.03M
P/E Ratio:
-4.1532
EPS:
-0.9005
Net Cash Flow:
$60.67M
1W Performance:
+3.45%
1M Performance:
+9.82%
6M Performance:
+68.69%
1Y Performance:
-29.21%
1-Day Range:
$3.62
$3.78
1-Week Range:
$3.37
$3.80
52-Week Range:
$1.665
$6.21
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Name
Maravai Lifesciences Holdings Inc
Sector
Industry
Phone
(858) 546-0004
Address
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Compare MRVI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
3.745 | 533.68M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
428.94 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
782.23 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.13 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
908.04 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.22 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Neutral |
| Dec-05-24 | Downgrade | Goldman | Neutral → Sell |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-13-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-10-24 | Initiated | Craig Hallum | Buy |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-08-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-23-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-09-23 | Downgrade | Goldman | Buy → Neutral |
| Jan-05-23 | Downgrade | UBS | Buy → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Nov-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Dec-16-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-15-20 | Initiated | BofA Securities | Buy |
| Dec-15-20 | Initiated | Credit Suisse | Outperform |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-15-20 | Initiated | Jefferies | Buy |
| Dec-15-20 | Initiated | Robert W. Baird | Outperform |
| Dec-15-20 | Initiated | Stifel | Buy |
| Dec-15-20 | Initiated | William Blair | Outperform |
| Dec-14-20 | Initiated | UBS | Buy |
View All
Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News
MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review
MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Is Maravai LifeSciences Holdings Inc. (MAR) stock undervalued at current priceMarket Weekly Review & AI Driven Price Predictions - newser.com
Published on: 2025-11-21 05:22:01 - newser.com
Will Maravai LifeSciences Holdings Inc. stock outperform value stocksQuarterly Market Review & Accurate Buy Signal Notifications - newser.com
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Maravai LifeSciences Holdings Inc. stock a top pick in earnings seasonJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - newser.com
Is Maravai LifeSciences Holdings Inc. (MAR) stock a good hedge against inflationEarnings Recap Report & Daily Growth Stock Tips - newser.com
Why Maravai LifeSciences Holdings Inc. (MAR) stock is a must watch tickerPortfolio Return Report & Fast Momentum Stock Entry Tips - newser.com
How forex fluctuations impact Maravai LifeSciences Holdings Inc. (MAR) stockJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
Is Maravai LifeSciences Holdings Inc. (MAR) stock suitable for passive index fundsSell Signal & AI Enhanced Trading Signals - newser.com
Published on: 2025-11-19 14:21:53 - newser.com
Why Maravai LifeSciences Holdings Inc. stock appeals to dividend seekersTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
Will Maravai LifeSciences Holdings Inc. (MAR) stock benefit from infrastructure bill2025 Trade Ideas & Weekly Momentum Picks - newser.com
Adversity is less terrifying than hope: Maravai LifeSciences Holdings Inc (MRVI) - Setenews
Maravai Lifesciences at Jefferies: Strategic Restructuring Focus By Investing.com - Investing.com Canada
Is Maravai LifeSciences Holdings Inc. stock a bargain at current levelsWeekly Trade Report & Precise Swing Trade Entry Alerts - newser.com
Will Maravai LifeSciences Holdings Inc. stock outperform tech sector in 2025Market Risk Report & Reliable Price Breakout Signals - newser.com
Maravai LifeSciences Holdings, Inc. (MRVI.MX) Company Profile & Facts - Yahoo! Finance Canada
Why Maravai LifeSciences Holdings Inc. stock remains on watchlistsJuly 2025 Setups & Detailed Earnings Play Strategies - newser.com
[Form 4] MARAVAI LIFESCIENCES HOLDINGS, INC. Insider Trading Activity - Stock Titan
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Maravai Lifesciences CEO Increases Stake with Significant Share Purchase (MRVI) - GuruFocus
Maravai Lifesciences Holdings Insider Bought Shares Worth $702,689, According to a Recent SEC Filing - MarketScreener
How Analyst Views on Maravai LifeSciences Are Shifting as the Story Evolves - Yahoo Finance
Goldman Sachs Downgrades Maravai LifeSciences Holdings (MRVI) - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Will Maravai LifeSciences Holdings Inc. stock reach all time highs in 2025Share Buyback & Real-Time Volume Spike Alerts - newser.com
Why Maravai LifeSciences Holdings Inc. stock remains resilientJuly 2025 Market Mood & Risk Managed Investment Strategies - newser.com
Maravai Lifesciences Holdings Inc Stock (MRVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Maravai Lifesciences Holdings Inc Stock (MRVI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Brust Bernd | Chief Executive Officer |
Nov 11 '25 |
Buy |
3.24 |
157,201 |
509,331 |
157,201 |
| Brust Bernd | Chief Executive Officer |
Nov 12 '25 |
Buy |
3.21 |
93,358 |
299,679 |
250,559 |
| ORESHACK KURT | General Counsel |
Jan 31 '25 |
Sale |
5.03 |
25,000 |
125,750 |
167,618 |
0.50%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):